EMERGENT BIOSOLUTIONS INC. Amortization of Debt Issuance Costs
EMERGENT BIOSOLUTIONS INC. (EBS) reported Amortization of Debt Issuance Costs of $3.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. amortization of debt issuance costs for the quarter ending 2026-06-30 was $1.60M, a 33.33% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. amortization of debt issuance costs for the quarter ending 2026-03-31 was $1.80M, a 21.74% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. amortization of debt issuance costs for the quarter ending 2025-12-31 was $2.60M, a 18.18% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. amortization of debt issuance costs for the quarter ending 2025-09-30 was $2.50M.
- EMERGENT BIOSOLUTIONS INC. amortization of debt issuance costs for fiscal 2025 was $9.80M, a 32.43% increase from fiscal 2024.
- EMERGENT BIOSOLUTIONS INC. amortization of debt issuance costs for fiscal 2024 was $7.40M, a 65.26% decline from fiscal 2023.
- EMERGENT BIOSOLUTIONS INC. amortization of debt issuance costs for fiscal 2023 was $21.30M, a 419.51% increase from fiscal 2022.
- EMERGENT BIOSOLUTIONS INC. amortization of debt issuance costs for fiscal 2022 was $4.10M, a 0.00% change from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 3 month as first filed | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 6 month as first filed | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 9 month as first filed | Amortization of Debt Issuance Costs 12 month | Amortization of Debt Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.40M 10-Q · filed 2026-08-06 | $6.00M derived: sum of 3 quarters · filed 2026-08-06 | $8.50M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $1.80M 10-Q · filed 2026-05-01 | $4.40M derived: sum of 2 quarters · filed 2026-05-01 | $6.90M derived: sum of 3 quarters · filed 2026-05-01 | $9.30M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $5.10M derived: sum of 2 quarters · filed 2026-02-27 | $7.50M derived: sum of 3 quarters · filed 2026-08-06 | $9.80M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $4.90M derived: sum of 2 quarters · filed 2026-08-06 | $7.20M 10-Q · filed 2025-10-30 | $9.40M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.70M 10-Q · filed 2026-08-06 | $6.90M derived: sum of 3 quarters · filed 2026-08-06 | $200.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $2.30M 10-Q · filed 2026-05-01 | $4.50M derived: sum of 2 quarters · filed 2026-05-01 | -$2.20M derived: sum of 3 quarters · filed 2026-05-01 | $2.80M derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$4.50M derived: sum of 2 quarters · filed 2026-02-27 | $500.00K derived: sum of 3 quarters · filed 2026-02-27 | $7.40M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | -$6.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$1.70M derived: sum of 2 quarters · filed 2025-10-30 | $5.20M 10-Q · filed 2025-10-30 | $10.90M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $11.90M 10-Q · filed 2025-08-07 | $17.60M derived: sum of 3 quarters · filed 2026-02-27 | $23.30M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $6.90M 10-Q · filed 2025-05-08 | $12.60M derived: sum of 2 quarters · filed 2026-02-27 | $18.30M derived: sum of 3 quarters · filed 2026-02-27 | $27.20M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $11.40M derived: sum of 2 quarters · filed 2026-02-27 | $20.30M derived: sum of 3 quarters · filed 2026-02-27 | $21.30M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | $5.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $14.60M derived: sum of 2 quarters · filed 2024-11-07 | $15.60M 10-Q · filed 2024-11-07 | $16.60M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2023-06-30 | $8.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $9.90M 10-Q · filed 2024-08-07 | $10.90M derived: sum of 3 quarters · filed 2025-03-04 | $12.00M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2023-03-31 | $1.00M 10-Q · filed 2024-05-02 | $2.00M derived: sum of 2 quarters · filed 2025-03-04 | $3.10M derived: sum of 3 quarters · filed 2025-03-04 | $4.10M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2022-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $2.10M derived: sum of 2 quarters · filed 2025-03-04 | $3.10M derived: sum of 3 quarters · filed 2025-03-04 | $4.10M 10-K · filed 2025-03-04 | ||||
| 2022-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-11 | $2.10M derived: sum of 2 quarters · filed 2023-12-11 | $3.10M 10-Q · filed 2023-12-11 | $4.10M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.00M 10-Q · filed 2023-08-09 | $3.00M derived: sum of 3 quarters · filed 2024-03-08 | $4.10M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-03-31 | $1.00M 10-Q · filed 2023-05-10 | $2.00M derived: sum of 2 quarters · filed 2024-03-08 | $3.10M derived: sum of 3 quarters · filed 2024-03-08 | $4.10M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2021-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $2.10M derived: sum of 2 quarters · filed 2024-03-08 | $3.10M derived: sum of 3 quarters · filed 2024-03-08 | $4.10M 10-K · filed 2024-03-08 | ||||
| 2021-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.10M derived: sum of 2 quarters · filed 2022-11-09 | $3.10M 10-Q · filed 2022-11-09 | $4.20M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $2.00M 10-Q · filed 2022-08-02 | $3.10M derived: sum of 3 quarters · filed 2023-12-11 | $4.00M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-03-31 | $1.00M 10-Q · filed 2022-04-29 | $2.10M derived: sum of 2 quarters · filed 2023-12-11 | $3.00M derived: sum of 3 quarters · filed 2023-12-11 | $3.80M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2020-12-31 | $1.10M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11 | $2.00M derived: sum of 2 quarters · filed 2023-12-11 | $2.80M derived: sum of 3 quarters · filed 2023-12-11 | $3.50M 10-K/A · filed 2023-12-11 | ||||
| 2020-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $1.70M derived: sum of 2 quarters · filed 2021-11-05 | $2.40M 10-Q · filed 2021-11-05 | $3.20M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $1.50M 10-Q · filed 2021-07-30 | $2.30M derived: sum of 3 quarters · filed 2022-02-25 | $3.00M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $700.00K 10-Q · filed 2021-04-30 | $1.50M derived: sum of 2 quarters · filed 2022-02-25 | $2.20M derived: sum of 3 quarters · filed 2022-02-25 | $3.00M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $1.50M derived: sum of 2 quarters · filed 2022-02-25 | $2.30M derived: sum of 3 quarters · filed 2022-02-25 | $3.00M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $1.50M derived: sum of 2 quarters · filed 2020-11-06 | $2.20M 10-Q · filed 2020-11-06 | $3.10M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $1.50M 10-Q · filed 2020-07-31 | $2.40M derived: sum of 3 quarters · filed 2021-02-19 | $2.40M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-03-31 | $700.00K 10-Q · filed 2020-05-01 | $1.60M derived: sum of 2 quarters · filed 2021-02-19 | $1.60M derived: sum of 3 quarters · filed 2021-02-19 | $1.50M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2018-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $900.00K derived: sum of 2 quarters · filed 2021-02-19 | $800.00K derived: sum of 3 quarters · filed 2021-02-19 | $900.00K 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$100.00K derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | $1.11M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $0.00 10-Q · filed 2019-08-02 | $1.11M derived: sum of 3 quarters · filed 2020-02-25 | $1.31M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | $100.00K 10-Q · filed 2019-05-08 | $1.21M derived: sum of 2 quarters · filed 2020-02-25 | $1.41M derived: sum of 3 quarters · filed 2020-02-25 | $1.60M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $1.31M derived: sum of 2 quarters · filed 2020-02-25 | $1.50M derived: sum of 3 quarters · filed 2020-02-25 | $1.70M 10-K · filed 2020-02-25 | $681.00K 10-K · filed 2018-02-23 | |||
| 2017-09-30 | $195.00K 10-Q · filed 2017-11-03 | $390.00K derived: sum of 2 quarters · filed 2017-11-03 | $586.00K 10-Q · filed 2017-11-03 | $797.00K derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2017-06-30 | $195.00K 10-Q · filed 2017-08-04 | $391.00K 10-Q · filed 2017-08-04 | $602.00K derived: sum of 3 quarters · filed 2018-02-23 | $785.00K derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2017-03-31 | $195.00K 10-Q · filed 2017-05-05 | $407.00K derived: sum of 2 quarters · filed 2018-02-23 | $590.00K derived: sum of 3 quarters · filed 2018-02-23 | $590.00K derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-12-31 | $212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $395.00K derived: sum of 2 quarters · filed 2018-02-23 | $395.00K derived: sum of 3 quarters · filed 2018-02-23 | $781.00K 10-K · filed 2018-02-23 | ||||
| 2016-09-30 | $183.00K 10-Q · filed 2017-11-03 | $183.00K derived: sum of 2 quarters · filed 2017-11-03 | $569.00K 10-Q · filed 2017-11-03 | $595.00K derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-04 | $391.00K 10-Q · filed 2017-08-04 | $0.00 10-Q · filed 2016-08-05 | $412.00K derived: sum of 3 quarters · filed 2018-02-23 | $627.00K derived: sum of 4 quarters · filed 2018-02-23 | |||
| 2016-03-31 | $215.00K 10-Q · filed 2017-05-05 | -$215.00K 10-Q · filed 2016-05-06 | $412.00K derived: sum of 2 quarters · filed 2018-02-23 | $627.00K derived: sum of 3 quarters · filed 2018-02-23 | $408.00K derived: sum of 4 quarters · filed 2018-02-23 | |||
| 2015-12-31 | $197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $412.00K derived: sum of 2 quarters · filed 2018-02-23 | $193.00K derived: sum of 3 quarters · filed 2018-02-23 | $868.00K 10-K · filed 2018-02-23 | -$868.00K 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $215.00K 10-Q · filed 2016-11-09 | -$215.00K 10-Q · filed 2015-11-06 | -$4.00K derived: sum of 2 quarters · filed 2016-11-09 | $671.00K 10-Q · filed 2016-11-09 | -$671.00K 10-Q · filed 2015-11-06 | $731.00K derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | -$219.00K 10-Q · filed 2016-08-05 | $0.00 10-Q · filed 2016-08-05 | $516.00K derived: sum of 3 quarters · filed 2017-02-28 | $313.00K derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-06 | $735.00K derived: sum of 2 quarters · filed 2017-02-28 | $532.00K derived: sum of 3 quarters · filed 2017-02-28 | $532.00K derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $735.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $532.00K derived: sum of 2 quarters · filed 2017-02-28 | $532.00K derived: sum of 3 quarters · filed 2017-02-28 | $735.00K 10-K · filed 2017-02-28 | -$735.00K 10-K · filed 2015-03-09 | |||
| 2014-09-30 | -$203.00K 10-Q · filed 2015-11-06 | -$203.00K derived: sum of 2 quarters · filed 2015-11-06 | $0.00 10-Q · filed 2015-11-06 | -$203.00K derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-08 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | |||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-08 | $0.00 10-Q · filed 2014-08-08 | ||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 | |||||||
| 2012-12-31 | $0.00 10-K · filed 2015-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |